HK1133393A1 - 用於肽構建體的氨基酸替代物 - Google Patents

用於肽構建體的氨基酸替代物

Info

Publication number
HK1133393A1
HK1133393A1 HK10100402.0A HK10100402A HK1133393A1 HK 1133393 A1 HK1133393 A1 HK 1133393A1 HK 10100402 A HK10100402 A HK 10100402A HK 1133393 A1 HK1133393 A1 HK 1133393A1
Authority
HK
Hong Kong
Prior art keywords
amino acid
acid surrogates
formula
ring
surrogates
Prior art date
Application number
HK10100402.0A
Other languages
English (en)
Inventor
‧夏爾馬
‧巴斯托斯
楊煒
蔡慧芝
Original Assignee
帕拉丁科技公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 帕拉丁科技公司 filed Critical 帕拉丁科技公司
Publication of HK1133393A1 publication Critical patent/HK1133393A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
    • B23B—TURNING; BORING
    • B23B31/00—Chucks; Expansion mandrels; Adaptations thereof for remote control
    • B23B31/02—Chucks
    • B23B31/10—Chucks characterised by the retaining or gripping devices or their immediate operating means
    • B23B31/12—Chucks with simultaneously-acting jaws, whether or not also individually adjustable
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mechanical Engineering (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK10100402.0A 2006-03-30 2010-01-14 用於肽構建體的氨基酸替代物 HK1133393A1 (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US74396406P 2006-03-30 2006-03-30
US74396306P 2006-03-30 2006-03-30
US74396006P 2006-03-30 2006-03-30
PCT/US2007/065632 WO2007115164A2 (en) 2006-03-30 2007-03-30 Amino acid surrogates for peptidic constructs

Publications (1)

Publication Number Publication Date
HK1133393A1 true HK1133393A1 (zh) 2010-03-26

Family

ID=38564240

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10100402.0A HK1133393A1 (zh) 2006-03-30 2010-01-14 用於肽構建體的氨基酸替代物

Country Status (13)

Country Link
EP (1) EP2004352B1 (zh)
JP (1) JP5424867B2 (zh)
KR (1) KR101393715B1 (zh)
CN (1) CN101484171B (zh)
AT (1) ATE539762T1 (zh)
AU (1) AU2007233105B2 (zh)
BR (1) BRPI0709405A2 (zh)
CA (1) CA2647114C (zh)
EA (1) EA200802060A1 (zh)
HK (1) HK1133393A1 (zh)
IL (1) IL194265A (zh)
MX (1) MX2008012649A (zh)
WO (1) WO2007115164A2 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8299023B2 (en) 2008-09-17 2012-10-30 Hoffmann-La Roche Inc. Neuropeptide-2 receptor (Y-2R) agonists
WO2020250159A1 (en) 2019-06-12 2020-12-17 Novartis Ag Natriuretic peptide receptor 1 antibodies and methods of use
CN110498750B (zh) * 2019-09-02 2021-10-15 南通大学 一种(r)-4-羟基-1-甲氧基丁-2-基氨基甲酸叔丁酯的合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1996555A (en) * 1931-05-27 1935-04-02 Cooper Bessemer Corp Engine fuel regulator
US4251438A (en) * 1979-06-14 1981-02-17 The Upjohn Company Piperazinone and piperazine polypeptides
US4341698A (en) * 1979-06-21 1982-07-27 Richardson-Merrell Inc. Enkaphalin derivatives
US5190922A (en) * 1991-06-04 1993-03-02 Abbott Laboratories Terminally modified tri-, tetra- and pentapeptide anaphylatoxin receptor ligands
TW394760B (en) * 1993-09-07 2000-06-21 Hoffmann La Roche Novel Carboxamides, process for their preparation and pharmaceutical composition containing the same
FR2717484A1 (fr) * 1994-03-16 1995-09-22 Pf Medicament Nouveaux composés pseudo-bis-peptidiques analogues de la CCK, leur procédé de préparation, leur utilisation à titre de médicament et les compositions pharmaceutiques les comprenant .
US5811241A (en) * 1995-09-13 1998-09-22 Cortech, Inc. Method for preparing and identifying N-substitued 1,4-piperazines and N-substituted 1,4-piperazinediones
CA2321302A1 (en) * 1998-02-27 1999-09-02 The Procter & Gamble Company Solid support synthesis of 2-oxopiperazines
US6462046B2 (en) * 2000-01-06 2002-10-08 Advanced Syntech, Llc Heterocycle derivatives as PPAR-gamma agonists
WO2002079172A1 (en) * 2000-12-12 2002-10-10 Chugai Seiyaku Kabushiki Kaisha Method for preparing monocyclic $i(n)-acyl-aminolactam compounds and combinatorial libraries thereof
US6911447B2 (en) * 2001-04-25 2005-06-28 The Procter & Gamble Company Melanocortin receptor ligands
US7456184B2 (en) 2003-05-01 2008-11-25 Palatin Technologies Inc. Melanocortin receptor-specific compounds
BRPI0709427A2 (pt) * 2006-03-30 2011-07-12 Palatin Technologies Inc "construto cìclico, composição farmacêutica e uso de um composto
JP2009532385A (ja) * 2006-03-30 2009-09-10 パラティン・テクノロジーズ・インコーポレーテッド 線状ナトリウム利尿ペプチド構築物

Also Published As

Publication number Publication date
AU2007233105A1 (en) 2007-10-11
CN101484171B (zh) 2015-05-06
CN101484171A (zh) 2009-07-15
JP5424867B2 (ja) 2014-02-26
KR101393715B1 (ko) 2014-05-13
EP2004352B1 (en) 2012-01-04
WO2007115164A2 (en) 2007-10-11
WO2007115164A9 (en) 2007-11-29
BRPI0709405A2 (pt) 2011-07-12
CA2647114A1 (en) 2007-10-11
ATE539762T1 (de) 2012-01-15
KR20090008310A (ko) 2009-01-21
CA2647114C (en) 2016-10-11
EP2004352A2 (en) 2008-12-24
EP2004352A4 (en) 2009-11-04
MX2008012649A (es) 2008-10-13
IL194265A (en) 2016-04-21
WO2007115164A3 (en) 2009-04-02
AU2007233105B2 (en) 2013-05-16
EA200802060A1 (ru) 2009-10-30
JP2009532382A (ja) 2009-09-10

Similar Documents

Publication Publication Date Title
TW200640926A (en) Pyrazolopyrimidines
ATE542803T1 (de) Verfahren zur herstellung von dihydrochinazolinen
TW200716636A (en) Heterocyclic spiro-compounds
SG170772A1 (en) Salts of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl- phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
JO2630B1 (en) Organic compounds
EP1782263A4 (en) PRODUCTION OF SWPM-MDT WORKFLOW
TW200720271A (en) DNA-PK inhibitors
MY150538A (en) Process for the manufacture of dihydropteridinones
MX2011013117A (es) Peptidos especificos del receptor de melanocortina.
ATE517094T1 (de) Verfahren zur herstellung von medetomidin und seinen salzen
MX2009004435A (es) Tinturas dispersas, su preparacion y su uso.
MY149705A (en) Pyridino-pyridinone derivatives, preparation therof, and therapeutic use thereof
TW200604149A (en) Norbornane based cycloaliphatic compounds containing nitrile groups
DE502008001158D1 (en) Benzimidazolderivate
GB2461659A (en) Structured compositions comprising a clay
CO5690637A2 (es) Tiazol-(bi) cicloalquil-carboxanilidas
ATE448234T1 (de) Olanzapin-analoga und verfahren zu ihrer verwendung
MY155410A (en) Compositions and devices
TW200637806A (en) 2-alkylcycloalk(en)ylcarboxamides
TW200613308A (en) Cyclobutanetetracarboxylate compound and preparation method thereof
TW200630348A (en) Tadalafil crystal forms and processes for preparing them
HK1133393A1 (zh) 用於肽構建體的氨基酸替代物
WO2010148177A3 (en) Compounds, compositions, methods of synthesis, and methods of treatment
ITCH20050004U1 (it) modulo di utilizzazione di fuido termovettore primario per l'alimentazione di utenze combinate.
TW200615274A (en) Chemical compounds

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190403